BioSpace News Archive

Drug Development

Eclipse Life Sciences Initiates Phase 2 Study for Novel Ophthalmology Steroid Implant for Diabetic Macular Edema (DME)

August 12, 2024
·
3 min read
Press Releases

Locus Biosciences Announces Positive Results from Part 1 of ELIMINATE Phase 2 Trial of the Engineered Bacteriophage Therapy LBP-EC01 Published in The Lancet Infectious Diseases

August 12, 2024
·
7 min read
Press Releases

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for VORANIGO® (vorasidenib)

August 12, 2024
·
2 min read
Business

Bitech Technologies Announces Business Update and Provides Key 2024 Milestones for BESS Projects

August 12, 2024
·
7 min read
Press Releases

Monopar Therapeutics Announces 1-for-5 Reverse Stock Split

August 12, 2024
·
4 min read
Press Releases

Tevogen Bio’s Founding CEO, Ryan Saadi, Expresses Conviction in Company’s Growth Strategy and Reaffirms Newly Effective Form S-1 Does Not Relate to Previously Undisclosed New Issuance of Dilutive Securities

August 12, 2024
·
7 min read
Press Releases

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - August 9, 2024

August 12, 2024
·
2 min read
Press Releases

Y-mAbs Reports Second Quarter 2024 Financial Results and Recent Corporate Developments

August 12, 2024
·
17 min read
Business

Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14

August 12, 2024
·
3 min read
Press Releases

Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma

August 12, 2024
·
7 min read